TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths November 2, 2002